<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">
Cryoport transportation image

When you need confidence in your cold chain… Trust Cryoport

Request a Quote

Upcoming Events View All


World Advanced Therapies & Regenerative Medicine Congress 2017

Date: May 17-19, 2017
Location: London, UK



CAR-TCR Summit 2017

Date: September 5-8, 2017
Location: Boston, MA

The Latest From Our Blog View All

Cold Chain Solutions for Autologous Cell Therapy Commercialization

Biopharmaceuticals are inherently fragile and temperature-sensitive, requiring exacting control of shipping and storage conditions to maintain product efficacy. This is especially critical for autologous therapies, where cold chain management solutions involving suitable packaging, storage and data collection, as well as tightly controlled logistics, are needed. As companies conduct clinical trials for these innovative therapies, it is the right time to begin building a comprehensive, integrated supply chain in anticipation of product commercialization. 

Using Real-World Data to Reduce Cold Chain Risk

When planning your cold chain logistics strategy for temperature-sensitive biologic materials, a key consideration is minimizing risk to the quality of the commodity and its on-time delivery. Today, there are tools available that optimize outcomes by using real-world data to create better predictive models for the delivery of shipments anywhere in the world.